I agree that this site is using cookies. You can find further informations here.
X
Sidiropoulos, Paris
46  results:
Search for persons X
?
1

Burden and cost of comorbidities in patients with neuromyel..:

Exuzides, Alex ; Sheinson, Daniel ; Sidiropoulos, Paris...
Journal of the Neurological Sciences.  427 (2021)  - p. 117530 , 2021
Link: https://doi.org/10.1016/..
 
?
2

Identification and temporal trends of patients with neuromy..:

Exuzides, Alex ; Wu, Ning ; Sheinson, Daniel...
Journal of Medical Economics.  24 (2021)  1 - p. 581-588 , 2021
Link: https://doi.org/10.1080/..
 
?
3

The costs of care from a US claims database in patients wit..:

Exuzides, Alex ; Sheinson, Daniel ; Sidiropoulos, Paris...
Journal of the Neurological Sciences.  427 (2021)  - p. 117553 , 2021
Link: https://doi.org/10.1016/..
 
?
4

358. RISK FACTORS FOR TREATMENT FAILURE IN PATIENTS WITH GI..:

Unizony, Sebastian ; Bao, Min ; Luder, Yves...
Rheumatology.  58 (2019)  Supplement_2 - p. , 2019
Link: https://doi.org/10.1093/..
 
?
5

274. CLINICAL OUTCOMES OF PATIENTS WITH GIANT CELL ARTERITI..:

Unizony, Sebastian ; Pei, Jinglan ; Sidiropoulos, Paris...
Rheumatology.  58 (2019)  Supplement_2 - p. , 2019
Link: https://doi.org/10.1093/..
 
?
6

Median time to low disease activity is shorter in tocilizum..:

Mueller, Ruediger B. ; Graninger, Winfried ; Sidiropoulos, Páris..
Clinical Rheumatology.  36 (2017)  10 - p. 2187-2192 , 2017
Link: https://doi.org/10.1007/..
 
?
7

Clinical outcomes of patients with giant cell arteritis tre..:

Unizony, Sebastian ; McCulley, Timothy J. ; Spiera, Robert...
Arthritis Research & Therapy.  23 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
8

Effect of disease duration and other characteristics on eff..:

Rubbert-Roth, Andrea ; Aletaha, Daniel ; Devenport, Jenny...
Rheumatology.  60 (2020)  2 - p. 682-691 , 2020
Link: https://doi.org/10.1093/..
 
?
9

Schwann cells, but not Oligodendrocytes, Depend Strictly on..:

Gerber, Daniel ; Ghidinelli, Monica ; Tinelli, Elisa...
eLife.  8 (2019)  - p. , 2019
Link: https://doi.org/10.7554/..
 
?
10

Long-term safety and effectiveness of tocilizumab in patien..:

Bykerk, Vivian P. ; Östör, Andrew J. K. ; Alvaro-Gracia, José...
Clinical Rheumatology.  38 (2019)  9 - p. 2411-2421 , 2019
Link: https://doi.org/10.1007/..
 
?
11

HDAC1/2-Dependent P0 Expression Maintains Paranodal and Nod..:

Brügger, Valérie ; Engler, Stefanie ; Pereira, Jorge A....
PLOS Biology.  13 (2015)  9 - p. e1002258 , 2015
Link: https://doi.org/10.1371/..
 
?
12

Dynamin 2 mutations in Charcot–Marie–Tooth neuropathy highl..:

Sidiropoulos, Páris N. M. ; Miehe, Michaela ; Bock, Thomas...
Brain.  135 (2012)  5 - p. 1395-1411 , 2012
Link: https://doi.org/10.1093/..
 
?
13

Myelin is dependent on the Charcot–Marie–Tooth Type 4H dise..:

Horn, Michael ; Baumann, Reto ; Pereira, Jorge A....
Brain.  135 (2012)  12 - p. 3567-3583 , 2012
Link: https://doi.org/10.1093/..
 
?
14

SH3TC2, a protein mutant in Charcot–Marie–Tooth neuropathy,..:

Stendel, Claudia ; Roos, Andreas ; Kleine, Henning...
Brain.  133 (2010)  8 - p. 2462-2474 , 2010
Link: https://doi.org/10.1093/..
 
?
15

Clinical outcomes of patients with giant cell arteritis tre..:

Unizony, Sebastian ; McCulley, Timothy J ; Spiera, Robert...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789742/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15